Ajani, J. A., Estrella, J. S., Chen, Q., Correa, A. M., Ma, L., Scott, A. W., . . . Song, S. (2018). Galectin-3 expression is prognostic in diffuse type gastric adenocarcinoma, confers aggressive phenotype, and can be targeted by YAP1/BET inhibitors. Br J Cancer.
Chicago Style CitationAjani, Jaffer A., et al. "Galectin-3 Expression Is Prognostic in Diffuse Type Gastric Adenocarcinoma, Confers Aggressive Phenotype, and Can Be Targeted By YAP1/BET Inhibitors." Br J Cancer 2018.
MLA CitationAjani, Jaffer A., et al. "Galectin-3 Expression Is Prognostic in Diffuse Type Gastric Adenocarcinoma, Confers Aggressive Phenotype, and Can Be Targeted By YAP1/BET Inhibitors." Br J Cancer 2018.
Warning: These citations may not always be 100% accurate.